糖尿病前期
减肥
医学
内分泌学
内科学
氧化应激
胰岛素
血压
胰岛素敏感性
胰岛素抵抗
肥胖
生物
糖尿病
2型糖尿病
作者
Elizabeth F. Sutton,Robbie A. Beyl,Kate Early,William T. Cefalu,Éric Ravussin,Courtney M. Peterson
出处
期刊:Cell Metabolism
[Elsevier]
日期:2018-05-10
卷期号:27 (6): 1212-1221.e3
被引量:1315
标识
DOI:10.1016/j.cmet.2018.04.010
摘要
Summary
Intermittent fasting (IF) improves cardiometabolic health; however, it is unknown whether these effects are due solely to weight loss. We conducted the first supervised controlled feeding trial to test whether IF has benefits independent of weight loss by feeding participants enough food to maintain their weight. Our proof-of-concept study also constitutes the first trial of early time-restricted feeding (eTRF), a form of IF that involves eating early in the day to be in alignment with circadian rhythms in metabolism. Men with prediabetes were randomized to eTRF (6-hr feeding period, with dinner before 3 p.m.) or a control schedule (12-hr feeding period) for 5 weeks and later crossed over to the other schedule. eTRF improved insulin sensitivity, β cell responsiveness, blood pressure, oxidative stress, and appetite. We demonstrate for the first time in humans that eTRF improves some aspects of cardiometabolic health and that IF's effects are not solely due to weight loss.
科研通智能强力驱动
Strongly Powered by AbleSci AI